US · TKNO
Alpha Teknova, Inc.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Hollister, CA 95023
- Website
- teknova.com
Price · as of 2025-12-31
$3.40
Market cap 138.11M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $27.72 | +715.29% |
| Intrinsic Value(DCF) | $0.95 | -72.06% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $2.54 | $10.40 | |||
| 2021 | $16.48 | $291.34 | $2.82 | $2.77 | $0.00 |
| 2022 | $3.78 | $18.34 | $0.00 | $0.00 | $0.00 |
| 2023 | $2.85 | $27.40 | $0.00 | $0.00 | $3.21 |
| 2024 | $6.09 | $28.41 | $0.00 | $0.00 | $0.00 |
| 2025 | $2.38 | $27.72 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Alpha Teknova, Inc.'s (TKNO) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $27.72
- Current price
- $3.40
- AI upside
- +715.29%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.95
-72.06% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| TKNO | Alpha Teknova, Inc. | $3.40 | 138.11M | +715% | -72% | — | — | -7.38 | 1.85 | 3.14 | -13.45 | — | 2.24 | 33.17% | -41.90% | -42.59% | -22.83% | -21.20% | -15.52% | 0.22 | -23.91 | 4.58 | 1.40 | -0.91 | -4386.00% | 735.00% | -3170.00% | -7.25% | -1.07 | -11.53% | 0.00% | 0.00% | 13.58% | -8.04 | -14.79 | 3.37 | 0.52 |
| ACB | Aurora Cannabis Inc. | $3.84 | 217.76M | +498% | -40% | +80% | -82% | 27.82 | 0.78 | 1.28 | 6.97 | — | 0.92 | 54.65% | 1.44% | 0.46% | 2.80% | 0.80% | 1.87% | 0.18 | 0.59 | 4.31 | 2.06 | -1.56 | -10223.00% | 2701.00% | -9666.00% | -0.65% | 0.15 | -0.59% | 0.00% | 0.00% | 0.12% | 72.30 | -125.35 | 1.04 | -8.43 |
| BIOA | BioAge Labs, Inc. | $22.27 | 798.49M | — | — | — | — | -0.69 | 0.15 | — | 4.33 | — | 0.15 | 0.00% | — | — | -94.98% | 95.18% | -37.02% | 0.03 | -33.04 | 12.86 | 12.76 | 5.04 | -2246.00% | — | 3826.00% | -106.31% | -1.85 | 63.16% | 0.00% | 0.00% | 772.94% | 3.80 | 5.72 | — | 0.23 |
| CGC | Canopy Growth Corporation | $1.12 | 576.26M | +725% | -39% | — | +204% | -0.42 | 0.52 | 0.95 | -0.99 | — | 0.72 | 29.56% | -43.55% | -222.35% | -122.35% | -14.04% | -54.48% | 0.72 | -1.57 | 3.12 | 1.95 | -0.49 | -3709.00% | -947.00% | -3809.00% | -69.30% | -1.76 | -21.21% | 0.00% | 0.00% | 102.99% | -4.03 | -2.67 | 1.76 | -16.18 |
| CVRX | CVRx, Inc. | $8.16 | 214.7M | +209% | -60% | — | — | -4.02 | 5.45 | 3.78 | -3.70 | — | 5.45 | 85.33% | -90.49% | -94.10% | -96.59% | -342.22% | -44.76% | 1.29 | -8.80 | 7.63 | 6.49 | 0.49 | -2302.00% | 1045.00% | 60.00% | -19.01% | -3.02 | -272.03% | 0.00% | 0.00% | 0.00% | -3.70 | -4.65 | 3.35 | -5.99 |
| IMMP | Immutep Limited | $2.80 | 412.14M | +523% | -76% | — | — | -5.97 | 2.55 | 72.72 | -3.80 | -35.82 | 2.69 | -1117.55% | -2506.49% | -1218.02% | -36.88% | -1019.26% | -34.27% | 0.01 | — | 11.69 | 10.17 | 1.05 | 1667.00% | 3128.00% | 7368.00% | -16.93% | -4.86 | -500.64% | 0.00% | 0.00% | 0.00% | -1.89 | -3.84 | 47.33 | 10.94 |
| IRWD | Ironwood Pharmaceuticals,… | $3.42 | 556.36M | +1,376% | -58% | -88% | — | 24.11 | -10.55 | 1.96 | 5.51 | 0.21 | -10.18 | 99.36% | 40.10% | 8.11% | -13.49% | 62.48% | 6.42% | -3.88 | 3.63 | 1.13 | 1.08 | -0.03 | 1171818.00% | -1572.00% | 2283.00% | 21.93% | 0.52 | 167.05% | 0.00% | 0.00% | 88.68% | 4.85 | 4.54 | 1.95 | 2.60 |
| LFCR | Lifecore Biomedical, Inc. | $7.20 | 269.76M | +1,115% | -61% | — | — | -6.29 | 182.17 | 1.89 | -41.53 | — | -14.53 | 31.27% | -13.38% | -30.04% | -612.08% | -13.25% | -15.70% | 97.92 | -0.79 | 2.84 | 1.72 | -13.91 | -48485.00% | 47.00% | -2490.00% | -5.60% | -0.01 | -10.46% | 0.00% | 0.00% | 1.05% | -21.22 | -26.87 | 2.84 | -0.01 |
| NEO | NeoGenomics, Inc. | $9.83 | 255.21M | +138% | -61% | — | — | -2.25 | 0.29 | 0.33 | 318.65 | -6.35 | 9.47 | 38.85% | -9.09% | -14.85% | -12.42% | -5.70% | -7.21% | 0.56 | -17.61 | 4.26 | 3.61 | 179.17 | 3548.00% | 1011.00% | -3602.00% | -8.95% | 0.06 | -1.92% | 0.00% | 0.00% | 0.00% | -8.41 | -25.53 | 0.76 | 0.46 |
| PRQR | ProQR Therapeutics N.V. | $1.59 | 167.5M | +4,852% | +2,420% | — | — | -4.80 | 1.50 | 7.05 | -0.05 | — | 1.50 | 100.00% | -161.18% | -146.86% | -41.35% | 56.30% | -17.34% | 0.19 | -28.29 | 3.95 | 3.84 | 5.48 | -286.00% | 19022.00% | -28740.00% | -28.37% | -0.94 | 70.36% | 0.00% | 0.00% | 16.97% | -0.04 | -0.03 | 0.06 | -2.22 |
| XGN | Exagen Inc. | $3.62 | 82.04M | +641% | +1,119% | — | — | -3.89 | 6.16 | 1.06 | -5.36 | — | 6.16 | 59.51% | -24.51% | -27.17% | -93.78% | -136.76% | -29.74% | 2.41 | -6.10 | 2.70 | 2.21 | -0.09 | -3806.00% | 589.00% | -978.00% | -23.46% | -0.98 | -138.35% | 0.00% | 0.00% | 0.00% | -4.38 | -4.33 | 1.07 | -7.36 |
About Alpha Teknova, Inc.
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
- CEO
- Stephen Gunstream
- Employees
- 173
- Beta
- 0.41
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.95 ÷ $3.40) − 1 = -72.06% (DCF, example).